comparemela.com

Latest Breaking News On - Sushil patel - Page 1 : comparemela.com

Bain Capital Life Sciences Investors LLC Takes $31.90 Million Position in Revolution Medicines, Inc. (NASDAQ:RVMD)

Bain Capital Life Sciences Investors LLC bought a new stake in Revolution Medicines, Inc. (NASDAQ:RVMD – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 1,112,396 shares of the company’s stock, valued at approximately $31,904,000. Revolution Medicines comprises 3.1% of Bain Capital Life […]

Jack-anders
Piper-sandler
Sushil-patel
Securities-exchange-commission
Rafferty-asset-management
Needham-company
Bain-capital-life-sciences-investors
Investment-management
Norges-bank
Nasdaq
Revolution-medicines-inc
Exchange-commission

Farrukh Dhondy | The 'cancelling' of all those you don't agree with might have gone too far…

Farrukh Dhondy | The 'cancelling' of all those you don't agree with might have gone too far…
asianage.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from asianage.com Daily Mail and Mail on Sunday newspapers.

Damascus
Dimashq
Syria
Ireland
Hertfordshire
United-kingdom
Egypt
Israel
Iraq
Iran
Dover
Kent

Revolution Medicines, Inc. (NASDAQ:RVMD) Receives $43.20 Average Target Price from Brokerages

Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) has been given an average rating of “Buy” by the ten analysts that are currently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year target […]

Piper-sandler
Jeff-cislini
Sushil-patel
Raymond-james
Nasdaq
Revolution-medicines-inc
Janus-henderson-group
Securities-exchange-commission
Revolution-medicines-company-profile
Needham-company
Paloma-partners-management-co
Farallon-capital-management

Replimune Group, Inc. (NASDAQ:REPL) CEO Sells $130,655.18 in Stock

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) CEO Sushil Patel sold 20,194 shares of the business’s stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $6.47, for a total value of $130,655.18. Following the completion of the sale, the chief executive officer now owns […]

Sushil-patel
Pricet-rowe-associates-inc
Replimune-group-company-profile
Securities-exchange-commission
Jacobs-levy-equity-management-inc
Replimune-group-inc
Institutional-investors-weigh-in-on-replimune-group
Nasdaq
Nan-fung-group-holdings-ltd
Acadian-asset-management
Clearbridge-investments
Replimune-group-trading

Replimune Group, Inc. (NASDAQ:REPL) CEO Sushil Patel Sells 20,194 Shares

Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) CEO Sushil Patel sold 20,194 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $6.47, for a total value of $130,655.18. Following the completion of the sale, the chief executive officer now owns 212,014 shares […]

Sushil-patel
Replimune-group-inc
Vanguard-group-inc
Fcpm-iii-services
Goldman-sachs-group-inc
Replimune-group
Quarter-for-replimune-group
Loomis-sayles-co
Securities-exchange-commission
Pricet-rowe-associates-inc
Replimune-group-company-profile
Replimune-group-price-performance

vimarsana © 2020. All Rights Reserved.